There are two main purposes to this study. One purpose is to compare the usual pre-surgery treatment alone to using nivolumab plus the usual treatment. Another purpose is to compare post-surgery treatment with nivolumab alone to using nivolumab plus ipilimumab.
Learn more about the EA2174 trial or call the Cancer Research Office at Pottstown Hospital (610-327-7772) or Reading Hospital (484-628-8193).
